Litta Modignani R, Barantani E, Mazzolari M, Pincetti Nervi M, Macchi R
Divisione di Medicina I, Ospedale Fatebenefratelli e Oftalmico, Milano.
Ann Ital Med Int. 1991 Oct-Dec;6(4):420-6.
A total of 67 patients with chronic autoimmune thyroid disease were followed, mainly as outpatients, for a period of a few months to over 15 years. The diagnosis was euthyroidism (n = 16, 23.8%), subclinical hypothyroidism (n = 20, 29.8%), primary hypothyroidism (n = 28, 41.7%) or hashitoxicosis (n = 3, 4.47%). Patients with goiters fit Hashimoto's original description of "struma lymphomatosa". The diagnosis was made on clinical grounds and the usual laboratory hormonal tests. Histological examination was carried out at surgery or by fine needle aspiration in 35 patients (52.2%), and a clinical diagnosis was made in 32 (47.7%). Three patients had juvenile Hashimoto's thyroiditis. Most patients were in the fourth, fifth or sixth decade (64.8%), and of these 12 (18%) had subclinical hypothyroidism, which should be suspected when thyrotropin (TSH) is twice the upper normal limit. In these cases thyrotropin releasing hormone (TRH) testing and evaluation of anti-thyroglobulin antibodies (TgAb) and anti-microsomal antigen antibodies (MsAb) are mandatory. Hypothyroidism with few symptoms develops insidiously in young or elderly patients; the most sensitive test is TSH assay in conjunction with tests for TgAb and MsAb. L-thyroxine administration may be harmful in older patients with late diagnosed primary hypothyroidism. Thyroid supplementation is suggested for patients with subclinical hypothyroidism if TSH values are above 10 mU/L; otherwise they should be followed up annually, as should patients with positive thyroid autoantibodies who are still euthyroid.
共有67例慢性自身免疫性甲状腺疾病患者接受随访,主要作为门诊患者,随访时间从几个月到超过15年不等。诊断结果为甲状腺功能正常(n = 16,23.8%)、亚临床甲状腺功能减退(n = 20,29.8%)、原发性甲状腺功能减退(n = 28,41.7%)或桥本甲状腺毒症(n = 3,4.47%)。甲状腺肿患者符合桥本氏最初对“淋巴细胞性甲状腺肿”的描述。诊断基于临床症状及常规实验室激素检测。35例患者(52.2%)在手术时或通过细针穿刺进行了组织学检查,32例(47.7%)进行了临床诊断。3例患者患有青少年桥本甲状腺炎。大多数患者年龄在40、50或60岁(64.8%),其中12例(18%)患有亚临床甲状腺功能减退,当促甲状腺激素(TSH)高于正常上限两倍时应怀疑此病。在这些病例中,促甲状腺激素释放激素(TRH)检测以及抗甲状腺球蛋白抗体(TgAb)和抗微粒体抗原抗体(MsAb)的评估是必需的。甲状腺功能减退在年轻或老年患者中隐匿起病,症状较少;最敏感的检测方法是TSH测定结合TgAb和MsAb检测。对于确诊较晚的老年原发性甲状腺功能减退患者,给予左甲状腺素可能有害。如果TSH值高于10 mU/L,建议对亚临床甲状腺功能减退患者进行甲状腺补充治疗;否则,应每年进行随访,甲状腺自身抗体阳性但甲状腺功能仍正常的患者也应如此。